Advertisement
Advertisement

ALDX

ALDX logo

Aldeyra Therapeutics, Inc.

5.54
USD
Sponsored
+0.45
+8.74%
Feb 06, 15:57 UTC -5
Closed
exchange

After-Market

5.35

-0.18
-3.32%

ALDX Earnings Reports

Positive Surprise Ratio

ALDX beat 25 of 40 last estimates.

63%

Next Report

Date of Next Report
Feb 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
$24.73M
/
-$0.17
Implied change from Q3 25 (Revenue/ EPS)
--
/
+30.77%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-37.04%

Aldeyra Therapeutics, Inc. earnings per share and revenue

On Nov 05, 2025, ALDX reported earnings of -0.13 USD per share (EPS) for Q3 25, beating the estimate of -0.24 USD, resulting in a 47.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 24.73 million USD, implying an increase of 30.77% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Aldeyra Therapeutics, Inc. reported EPS of -$0.13, beating estimates by 47.98%, and revenue of $0.00, 0% as expectations.
The stock price moved down -2.43%, changed from $4.93 before the earnings release to $4.81 the day after.
The next earning report is scheduled for Feb 26, 2026.
Based on 8 analysts, Aldeyra Therapeutics, Inc. is expected to report EPS of -$0.17 and revenue of $24.73M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement